Convergence Investment Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.05M | Buy |
46,789
+21,196
| +83% | +$2.03M | 0.66% | 44 |
|
|
2025
Q4 | $2.46M | Sell |
25,593
-46
| -0.2% | -$4.47K | 0.49% | 58 |
|
|
2025
Q3 | $2.44M | Buy |
25,639
+1,467
| +6% | +$135K | 0.55% | 48 |
|
|
2025
Q2 | $2.11M | Sell |
24,172
-8,008
| -25% | -$679K | 0.53% | 52 |
|
|
2025
Q1 | $2.89M | Buy |
32,180
+10,324
| +47% | +$924K | 0.8% | 28 |
|
|
2024
Q4 | $1.75M | Sell |
21,856
-9,043
| -29% | -$783K | 0.39% | 83 |
|
|
2024
Q3 | $2.78M | Buy |
30,899
+9,324
| +43% | +$784K | 0.75% | 34 |
|
|
2024
Q2 | $1.7M | Buy |
21,575
+19,157
| +792% | +$1.57M | 0.5% | 56 |
|
|
2024
Q1 | $211K | Sell |
2,418
-10
| -0.4% | -$853 | 0.08% | 235 |
|
|
2023
Q4 | $200K | Buy |
+2,428
| New | +$185K | 0.1% | 187 |
|
|
2023
Q3 | – | Sell |
-2,357
| Closed | -$208K | – | 183 |
|
|
2023
Q2 | $208K | Buy |
+2,357
| New | +$203K | 0.12% | 157 |
|
|
2022
Q4 | – | Sell |
-2,575
| Closed | -$208K | – | 232 |
|
|
2022
Q3 | $208K | Sell |
2,575
-108
| -4% | -$9.71K | 0.14% | 150 |
|
|
2022
Q2 | $241K | Sell |
2,683
-51
| -2% | -$5.17K | 0.15% | 144 |
|
|
2022
Q1 | $303K | Sell |
2,734
-10
| -0.4% | -$1.06K | 0.16% | 135 |
|
|
2021
Q4 | $284K | Sell |
2,744
-152
| -5% | -$17.6K | 0.14% | 143 |
|
|
2021
Q3 | $363K | Sell |
2,896
-88
| -3% | -$11.4K | 0.2% | 118 |
|
|
2021
Q2 | $370K | Sell |
2,984
-166
| -5% | -$20.8K | 0.16% | 134 |
|
|
2021
Q1 | $372K | Sell |
3,150
-73
| -2% | -$8.56K | 0.17% | 124 |
|
|
2020
Q4 | $378K | Buy |
3,223
+70
| +2% | +$7.71K | 0.19% | 117 |
|
|
2020
Q3 | $328K | Sell |
3,153
-65
| -2% | -$6.53K | 0.11% | 206 |
|
|
2020
Q2 | $295K | Buy |
3,218
+205
| +7% | +$19.7K | 0.1% | 196 |
|
|
2020
Q1 | $272K | Sell |
3,013
-10,260
| -77% | -$1.09M | 0.12% | 192 |
|
|
2019
Q4 | $1.51M | Sell |
13,273
-10,255
| -44% | -$1.13M | 0.43% | 73 |
|
|
2019
Q3 | $2.56M | Buy |
23,528
+20,085
| +583% | +$2.1M | 0.71% | 38 |
|
|
2019
Q2 | $335K | Sell |
3,443
-6,774
| -66% | -$618K | 0.08% | 191 |
|
|
2019
Q1 | $931K | Sell |
10,217
-15,185
| -60% | -$1.36M | 0.2% | 163 |
|
|
2018
Q4 | $2.31M | Buy |
25,402
+9,554
| +60% | +$893K | 0.53% | 58 |
|
|
2018
Q3 | $1.56M | Buy |
15,848
+13,106
| +478% | +$1.21M | 0.32% | 120 |
|
|
2018
Q2 | $235K | Buy |
2,742
+40
| +1% | +$3.34K | 0.03% | 285 |
|
|
2018
Q1 | $217K | Buy |
2,702
+178
| +7% | +$14.7K | 0.03% | 281 |
|
|
2017
Q4 | $204K | Buy |
+2,524
| New | +$202K | 0.03% | 291 |
|
|
2017
Q3 | – | Sell |
-2,319
| Closed | -$206K | – | 369 |
|
|
2017
Q2 | $206K | Buy |
+2,319
| New | +$196K | 0.03% | 336 |
|
|
2015
Q2 | – | Sell |
-3,002
| Closed | -$234K | – | 386 |
|
|
2015
Q1 | $234K | Buy |
+3,002
| New | +$228K | 0.03% | 337 |
|
|
2014
Q1 | – | Sell |
-35,287
| Closed | -$2.02M | – | 408 |
|
|
2013
Q4 | $2.02M | Buy |
+35,287
| New | +$2M | 0.33% | 112 |
|
Other funds holding MDT
VCM
VPM
Convergence Investment Partners's MDT Position: Q1 2026 in Review
Convergence Investment Partners increased its Medtronic (MDT) stake by 83% in Q1 2026, buying an estimated $2.03M and bringing the position to 46,789 shares worth $4.05M. The position accounts for 0.66% of the portfolio, ranked #44.
Convergence Investment Partners first reported a position in MDT in Q4 2013 and has held it in 34 quarters since. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Convergence Investment Partners held 46,789 shares of Medtronic worth $4.05M as of Q1 2026.
- Convergence Investment Partners bought 21,196 Medtronic shares in Q1 2026, an estimated $2.03M.
- Medtronic made up 0.66% of Convergence Investment Partners's portfolio in Q1 2026, its #44 holding.
- Convergence Investment Partners first reported a position in Medtronic in Q4 2013 and has held it in 34 quarters since.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Convergence Investment Partners's 13F filing for Q1 2026, filed 7 May 2026.